|
The struggles of the nascent private-capital market, weighed down by lending to software companies whose businesses are under attack from artificial intelligence, has captured the eye of the market and the news media.
|
|
Astorg has agreed a roughly $1bn buyout of Thermo Fisher Scientific's microbiology business. The arm, which provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food safety testing, generated $645m in revenue last year. Thermo Fisher expects the deal to close in the second half of 2026. Astorg said the market was […]
The post Deal Roundup: Astorg agrees $1bn buyout of Thermo Fisher microbiology unit, O2 Investment backs Steffl Drilling & Pump appeared first on AltAssets Private Equity News.
|
|
